CSL Ltd.

Pharmaceuticals
Australia
Earnings Per Share Growth (%)8.29%
Cost of Goods Sold (US$ Millions)$2,606
Current Liabilities (US$ Millions)$936
Total Assets (US$ Millions)$3,339
Long Term Debt$2,278
Return on Equity43.61%
Revenue (US$ Millions)$5,459
Total Company Assets$6,401
Revenue Growth (%)2.32%
Net Income (US$ Millions)$1,379
Earnings Per Share (US$)$8.29
Total Equity (US$ Millions)$2,747
Profit Margin (%)25.26%
Debt To Equity Ratio (%)0.83%
Inventory Turnover$1,756